Stocktoria
Tectonic Therapeutic, Inc. TECX
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2018-06-21
Chart by TradingView
3/9
Piotroski F — financial health
28.46
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials & ratios (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Financials | |||||
| Operating income | -$84.0M | -$58.0M | -$44.6M | -$105.4M | -$118.8M |
| Net income | -$74.2M | -$58.0M | -$42.8M | -$105.9M | -$119.1M |
| Operating cash flow | -$60.1M | -$59.1M | -$40.7M | -$97.2M | -$98.0M |
| Free cash flow | -$60.3M | -$59.2M | -$41.0M | -$97.5M | -$100.5M |
| Total assets | $261.0M | $152.9M | $39.4M | $103.9M | $203.8M |
| Total liabilities | $9.7M | $12.1M | $43.4M | $28.6M | $34.4M |
| Shareholders' equity | $251.3M | $140.8M | -$84.6M | -$45.7M | $169.5M |
| Ratios | |||||
| Return on assets | -28.4% | -37.9% | -108.7% | -101.9% | -58.4% |
| Return on equity | -29.5% | -41.2% | 50.6% | 231.9% | -70.3% |
| Debt / equity | — | — | — | -0.33× | 0.09× |
| Current ratio | 26.63 | 12.65 | 0.76 | 7.62 | 10.27 |
Notable holders (13F)
| Investor | Shares | Value |
|---|---|---|
| Point72 Asset Management, L.P. | 68,598 | $2.1M |
Why these scores methodology →
Piotroski F-score: 3/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 28.46 (safe)
- Working capital / assets 0.949
- Retained earnings / assets -0.853
- EBIT / assets -0.322
- Equity / liabilities 25.886
Sector peers
VFS · TM · HMC · SONY · AAPL · XOM · all Manufacturing →
Source: SEC EDGAR filings · CIK 0001681087 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.